Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
National Academies Press
c2010
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index Introduction -- Surveillance -- Knowledge and awareness about chronic hepatitis B and hepatitis C -- Immunization -- Viral hepatitis services "The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations."--Publisher's description |
| Beschreibung: | 1 Online-Ressource (xix, 232 p.) |
| ISBN: | 0309146291 9780309146296 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043067994 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 0309146291 |c electronic bk. |9 0-309-14629-1 | ||
| 020 | |a 9780309146296 |c electronic bk. |9 978-0-309-14629-6 | ||
| 035 | |a (OCoLC)648761504 | ||
| 035 | |a (DE-599)BVBBV043067994 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.99/436 |2 22 | |
| 245 | 1 | 0 | |a Hepatitis and liver cancer |b a national strategy for prevention and control of hepatitis B and C |c Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice |
| 264 | 1 | |a Washington, DC |b National Academies Press |c c2010 | |
| 300 | |a 1 Online-Ressource (xix, 232 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Introduction -- Surveillance -- Knowledge and awareness about chronic hepatitis B and hepatitis C -- Immunization -- Viral hepatitis services | ||
| 500 | |a "The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations."--Publisher's description | ||
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a Hepatitis B. |2 fast | |
| 650 | 7 | |a Hepatitis C. |2 fast | |
| 650 | 7 | |a Liver / Cancer |2 fast | |
| 650 | 4 | |a Hepatitis B / complications / United States | |
| 650 | 4 | |a Hepatitis B / prevention & control / United States | |
| 650 | 4 | |a Hepatitis C / complications / United States | |
| 650 | 4 | |a Hepatitis C / prevention & control / United States | |
| 650 | 4 | |a Liver Neoplasms / prevention & control / United States | |
| 650 | 4 | |a Viral Hepatitis Vaccines / therapeutic use / United States | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Hepatitis B |z United States | |
| 650 | 4 | |a Hepatitis C |z United States | |
| 650 | 4 | |a Liver |x Cancer |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Colvin, Heather M. |e Sonstige |4 oth | |
| 700 | 1 | |a Mitchell, Abigail E. |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Committee on the Prevention and Control of Viral Hepatitis Infections |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Board on Population Health and Public Health Practice |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 0-309-14628-3 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-309-14628-9 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028492186 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175448740986880 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043067994 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)648761504 (DE-599)BVBBV043067994 |
| dewey-full | 616.99/436 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/436 |
| dewey-search | 616.99/436 |
| dewey-sort | 3616.99 3436 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04782nmm a2200613zc 4500</leader><controlfield tag="001">BV043067994</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309146291</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-14629-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309146296</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-14629-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)648761504</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043067994</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/436</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hepatitis and liver cancer</subfield><subfield code="b">a national strategy for prevention and control of hepatitis B and C</subfield><subfield code="c">Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xix, 232 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introduction -- Surveillance -- Knowledge and awareness about chronic hepatitis B and hepatitis C -- Immunization -- Viral hepatitis services</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations."--Publisher's description</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B.</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis C.</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Liver / Cancer</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B / complications / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B / prevention & control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C / complications / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C / prevention & control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liver Neoplasms / prevention & control / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viral Hepatitis Vaccines / therapeutic use / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis C</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liver</subfield><subfield code="x">Cancer</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Colvin, Heather M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mitchell, Abigail E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on the Prevention and Control of Viral Hepatitis Infections</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Board on Population Health and Public Health Practice</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">0-309-14628-3</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-309-14628-9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028492186</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV043067994 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:16:27Z |
| institution | BVB |
| isbn | 0309146291 9780309146296 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028492186 |
| oclc_num | 648761504 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xix, 232 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice Washington, DC National Academies Press c2010 1 Online-Ressource (xix, 232 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Introduction -- Surveillance -- Knowledge and awareness about chronic hepatitis B and hepatitis C -- Immunization -- Viral hepatitis services "The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care. Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood. Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations."--Publisher's description MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Hepatitis B. fast Hepatitis C. fast Liver / Cancer fast Hepatitis B / complications / United States Hepatitis B / prevention & control / United States Hepatitis C / complications / United States Hepatitis C / prevention & control / United States Liver Neoplasms / prevention & control / United States Viral Hepatitis Vaccines / therapeutic use / United States Medizin Hepatitis B United States Hepatitis C United States Liver Cancer United States USA Colvin, Heather M. Sonstige oth Mitchell, Abigail E. Sonstige oth Institute of Medicine (U.S.) Committee on the Prevention and Control of Viral Hepatitis Infections Sonstige oth Institute of Medicine (U.S.) Board on Population Health and Public Health Practice Sonstige oth Erscheint auch als Druckausgabe 0-309-14628-3 Erscheint auch als Druckausgabe 978-0-309-14628-9 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075 Aggregator Volltext |
| spellingShingle | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Hepatitis B. fast Hepatitis C. fast Liver / Cancer fast Hepatitis B / complications / United States Hepatitis B / prevention & control / United States Hepatitis C / complications / United States Hepatitis C / prevention & control / United States Liver Neoplasms / prevention & control / United States Viral Hepatitis Vaccines / therapeutic use / United States Medizin Hepatitis B United States Hepatitis C United States Liver Cancer United States |
| title | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C |
| title_auth | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C |
| title_exact_search | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C |
| title_full | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice |
| title_fullStr | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice |
| title_full_unstemmed | Hepatitis and liver cancer a national strategy for prevention and control of hepatitis B and C Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice |
| title_short | Hepatitis and liver cancer |
| title_sort | hepatitis and liver cancer a national strategy for prevention and control of hepatitis b and c |
| title_sub | a national strategy for prevention and control of hepatitis B and C |
| topic | MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Hepatitis B. fast Hepatitis C. fast Liver / Cancer fast Hepatitis B / complications / United States Hepatitis B / prevention & control / United States Hepatitis C / complications / United States Hepatitis C / prevention & control / United States Liver Neoplasms / prevention & control / United States Viral Hepatitis Vaccines / therapeutic use / United States Medizin Hepatitis B United States Hepatitis C United States Liver Cancer United States |
| topic_facet | MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Hepatitis B. Hepatitis C. Liver / Cancer Hepatitis B / complications / United States Hepatitis B / prevention & control / United States Hepatitis C / complications / United States Hepatitis C / prevention & control / United States Liver Neoplasms / prevention & control / United States Viral Hepatitis Vaccines / therapeutic use / United States Medizin Hepatitis B United States Hepatitis C United States Liver Cancer United States USA |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=326075 |
| work_keys_str_mv | AT colvinheatherm hepatitisandlivercanceranationalstrategyforpreventionandcontrolofhepatitisbandc AT mitchellabigaile hepatitisandlivercanceranationalstrategyforpreventionandcontrolofhepatitisbandc AT instituteofmedicineuscommitteeonthepreventionandcontrolofviralhepatitisinfections hepatitisandlivercanceranationalstrategyforpreventionandcontrolofhepatitisbandc AT instituteofmedicineusboardonpopulationhealthandpublichealthpractice hepatitisandlivercanceranationalstrategyforpreventionandcontrolofhepatitisbandc |